You are here: Industry Insights > teva

News List

Teva Announces U.S. Launch of a Generic Version of Sabril americanpharmaceuticalreview
February 14, 2019
Teva Pharmaceutical announced the launch of a generic version of Sabril (vigabatrin) tablets, 500 mg in the US, the first generic version of Sabril tablets to enter the US market.....
Teva’s generic EpiPen launch stalls months after approval biospectrumasia
February 02, 2019
The short supply represents a missed opportunity for Teva to compete with Mylan in a roughly $750 million a year US market
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen firstwordpharma
January 28, 2019
A spokesperson for CVS Health said that the company would exclusively cover new migraine drugs from Eli Lilly and Teva, as reported NASDAQ Friday.
Pharma stocks fall after new drug price probe in US pharmaphorum
January 16, 2019
US politicians from the resurgent Democratic party have launched a probe into “unsustainable” drug price rises, prompting their shares to drop suddenly.
Teva Announces FDA Approval of Digital Inhaler with Built-In Sensors americanpharmaceuticalreview
January 11, 2019
Teva Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has approved ProAir Digihaler (albuterol sulfate 117 mcg) inhalation powder, the first and only digital inhaler with built-in sensors which ....
Teva to produce new biosimilar drugs outside Israel firstwordpharma
January 10, 2019
People close to the matter revealed that Teva plans to manufacture a new biosimilar outside Israel, Globes reported Wednesday.
Teva to produce new biosimilar drugs outside Israel firstwordpharma
January 10, 2019
People close to the matter revealed that Teva plans to manufacture a new biosimilar outside Israel, Globes reported Wednesday.
Teva's escaped the generics 'death spiral,' but it can't take all the credit: CEO fiercepharma
January 09, 2019
A year ago at the J.P. Morgan Healthcare Conference, new Teva CEO Kåre Schultz detailed his plan to get the struggling drugmaker back on track. In 2019, he reported that things were playing out as planned—partly thanks to a factor he “couldn’t predict” la
Teva and Neos settle over Cotempla patent dispute pharmaphorum
December 29, 2018
Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over the Israeli firm’s generic version of Neos’ ADHD drug Cotempla XR-ODT (methylphenidate).
Celltrion/Teva’s Herceptin biosimilar approved in US pharmaphorum
December 18, 2018
The FDA has approved Celltrion and Teva’s biosimilar of Roche’s breast cancer drug Herceptin, the second potential competitor to the cancer blockbuster in the US.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page